HeartBeam Granted Patent for Signal Transformation from Vector Electrocardiogram (VECG) to 12-Lead Electrocardiogram (ECG)

Stock Information for Heartbeam Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Heartbeam Inc.

HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias
HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results
First Patients Enrolled in Pivotal Study Evaluating HeartBeam's AIMIGo(TM) System for Synthesizing a 12-Lead ECG
HeartBeam Receives Two New US Patents for its Core Cardiac Monitoring Technology
HeartBeam to Host Fourth Quarter and Full Year 2023 Results Conference Call on Wednesday March 20, 2024 at 4:30 p.m. Eastern Time
HeartBeam Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights
HeartBeam Reports Third Quarter 2023 Financial Results
HeartBeam Announces Expansion of Its Scientific Advisory Board

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.